EP1575359A4 - Reduction of reactive oxygen species in chronic wound management - Google Patents

Reduction of reactive oxygen species in chronic wound management

Info

Publication number
EP1575359A4
EP1575359A4 EP03808544A EP03808544A EP1575359A4 EP 1575359 A4 EP1575359 A4 EP 1575359A4 EP 03808544 A EP03808544 A EP 03808544A EP 03808544 A EP03808544 A EP 03808544A EP 1575359 A4 EP1575359 A4 EP 1575359A4
Authority
EP
European Patent Office
Prior art keywords
reduction
oxygen species
reactive oxygen
chronic wound
wound management
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03808544A
Other languages
German (de)
French (fr)
Other versions
EP1575359A1 (en
Inventor
Stephen H Monroe
Hans Hoekstra
Den Berg A J J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of EP1575359A1 publication Critical patent/EP1575359A1/en
Publication of EP1575359A4 publication Critical patent/EP1575359A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
EP03808544A 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management Withdrawn EP1575359A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
US436197P 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (2)

Publication Number Publication Date
EP1575359A1 EP1575359A1 (en) 2005-09-21
EP1575359A4 true EP1575359A4 (en) 2009-08-05

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03808544A Withdrawn EP1575359A4 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Country Status (6)

Country Link
EP (1) EP1575359A4 (en)
JP (1) JP2006511585A (en)
CN (1) CN1744819A (en)
AU (1) AU2003303335A1 (en)
CA (1) CA2511440A1 (en)
WO (1) WO2004057965A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
US20140194803A1 (en) * 2011-07-28 2014-07-10 Regents Of The University Of Minnestoa Wound-healing compositions and method of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (en) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Topical pharmaceutical formulations, process for the preparation thereof and the use thereof for promoting wound granulation and epithelisation
WO2003045366A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9307401A (en) * 1992-11-06 1999-08-24 H E Stanley Pharmaceuticals In Oak bark extract compositions related synthetic compositions and method of using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (en) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Topical pharmaceutical formulations, process for the preparation thereof and the use thereof for promoting wound granulation and epithelisation
WO2003045366A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREWS M ET AL: "The role of zinc in wound healing", ADVANCES IN WOUND CARE : THE JOURNAL FOR PREVENTION AND HEALING,, vol. 12, no. 3, 1 April 1999 (1999-04-01), pages 137 - 138, XP009112199, ISSN: 1076-2191 *
See also references of WO2004057965A1 *

Also Published As

Publication number Publication date
CA2511440A1 (en) 2004-07-15
CN1744819A (en) 2006-03-08
AU2003303335A1 (en) 2004-07-22
WO2004057965A1 (en) 2004-07-15
EP1575359A1 (en) 2005-09-21
JP2006511585A (en) 2006-04-06

Similar Documents

Publication Publication Date Title
EP1802214B8 (en) Compact having slidable in and out structure of content case
AU2002244776A1 (en) Enhanced storing of personal content
AU2002318298A1 (en) Defining external parameters in spreadsheets
GB2388046B (en) Gaming apparatus with power saving feature
GB0324429D0 (en) Improvements in and relating to gaming systems
AU2003301154A8 (en) Methods for managing a pool of multicast addresses and allocating addresses in a communications system
GB0215023D0 (en) Wound dressing
HK1082194A1 (en) Composition comprising echovirus ev1 and its use ev1
EP1551384A4 (en) R-nsaid esters and their use
EP1575359A4 (en) Reduction of reactive oxygen species in chronic wound management
AU2003295178A1 (en) Sinusoid selection in audio encoding
AU2003234599A8 (en) Methods and compounds for reducing biofilm formation
GB2394428B (en) Improvements in and relating to filters
GB0226436D0 (en) Improvements in and relating to catheter control
AU2003276636A1 (en) Sinusoid selection in audio encoding
GB0217220D0 (en) Improvements in and relating to tape measures
AU2003203237A1 (en) Structure of skylight in greenhouse
GB0224180D0 (en) Improved oxygen storage component
GB0213402D0 (en) Improvements in coated equipment
EP1541685A4 (en) Factor participating in transcriptional regulation
GB0404222D0 (en) Unitary construction block for use in building industry and building structure made therefrom
GB2388994B (en) Improvements in and relating to sound emitting devices
GB0325598D0 (en) Compound and use in treatment
HU0200114V0 (en) Calculator for recalculation of units and currencies
AU2003230049A8 (en) Improvements in and relating to speaker systems

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050630

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1081074

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090706

17Q First examination report despatched

Effective date: 20110218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110629

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1081074

Country of ref document: HK